The protein MTA1 has already been investigated as a potential prognostic factor in other gynecologic tumors, such as ovarian, cervical, and endometrial carcinoma, and correlated with tumor progression and metastases (Balasenthil et al. 2006; Dannenmann et al. 2008; Bruning et al. 2014). The gene discussed is MTA1; the disease is neoplasm.